Mutations in WD repeat domain 36 gene (WDR36) play a causative role in some forms of primary open-angle glaucoma, a leading cause of blindness worldwide. WDR36 is characterized by the presence of multiple WD40 repeats and shows homology to Utp21, an essential protein component of the yeast small subunit (SSU) processome required for maturation of 18S rRNA. To clarify the functional role of WDR36 in the mammalian organism, we generated and investigated mutant mice with a targeted deletion of Wdr36. In parallel experiments, we used RNA interference to deplete WDR36 mRNA in mouse embryos and cultured human trabecular meshwork (HTM-N) cells. Deletion of Wdr36 in the mouse caused preimplantation embryonic lethality, and essentially similar effects were observed when WDR36 mRNA was depleted in mouse embryos by RNA interference. Depletion of WDR36 mRNA in HTM-N cells caused apoptotic cell death and upregulation of mRNA for BAX, TP53 and CDKN1A. By immunocytochemistry, staining for WDR36 was observed in the nucleolus of cells, which co-localized with that of nucleolar proteins such as nucleophosmin and PWP2. In addition, recombinant and epitope-tagged WDR36 localized to the nucleolus of HTM-N cells. By northern blot analysis, a substantial decrease in 21S rRNA, the precursor of 18S rRNA, was observed following knockdown of WDR36. In addition, metabolic-labeling experiments consistently showed a delay of 18S rRNA maturation in WDR36-depleted cells. Our results provide evidence that WDR36 is an essential protein in mammalian cells which is involved in the nucleolar processing of SSU 18S rRNA.
INTRODUCTION
Glaucoma, the second leading cause of blindness worldwide (1) , is a chronic, degenerative optic neuropathy characterized by a progressive degeneration of optic nerve axons leading to typical visual field defects (2) . In the most common form, primary open-angle glaucoma (POAG), the resistance to outflow of aqueous humor increases in the trabecular meshwork outflow pathways, a condition that leads to an increase in intraocular pressure (IOP) (3, 4) . In several prospective, randomized, multicenter clinical studies, IOP has been identified as the most critical risk factor for the development of optic nerve axonal damage in POAG (5 -10). The neurotrophin hypothesis of POAG proposes that abnormally high IOP causes an obstruction of retrograde transport in optic nerve axons at the optic nerve head, a scenario that results in the deprivation of neurotrophic support to retinal ganglion cells (RGC) leading to their apoptotic cell death and to vision loss (11, 12) .
Susceptibility to POAG may be inherited as a Mendelian trait, or, probably in most cases, may depend on complex trait inheritance resulting from interactions of multiple genetic factors and the influence of environmental exposures (13, 14) . To date, at least 14 loci (GLC1A to GLC1N) that contribute to the susceptibility of POAG have been localized, and three genes have been identified within these loci: myocilin (MYOC) (15) , optineurin (OPTN) (16) and the WD repeat domain 36 gene (WDR36) (17) . Mutations in MYOC were reported in 3 -5% of patients with adult-onset POAG and in 20% of patients with juvenile POAG (18, 19) . MYOC encodes myocilin, a secreted protein with high expression in the trabecular meshwork. Neither the function nor the role of myocilin in the pathogenesis of POAG has been identified (20 -22) . Mutations in optineurin, a Golgi-associated protein (23 -25) , are rare events and are found at a frequency of ,1% in POAG patients (13, 14) . Sequence variants in WDR36 have been identified in the GLC1G locus mapped to 5q22.1 (17) . Subsequent studies have confirmed the presence of several non-synonymous WDR36 sequence alterations exclusive to POAG patients, but also a considerable number of variants in normal controls (26) (27) (28) (29) (30) (31) (32) (33) . In addition, patients with WDR36 sequence variations were reported to be associated with a more severe disease phenotype than those without (29) . Overall, the available data suggest that WDR36 plays a role as glaucoma-modifier gene that is involved rather in disease susceptibility than in causation (13, 14) . Such a role may not be confined to POAG as more recent studies identified WDR36 sequence variants in patients with high numbers of eosinophil leukocytes associated with allergic disorders such as atopic asthma or pediatric eosinophil esophagitis (34, 35) .
WDR36 is expressed in multiple ocular and non-ocular tissues, and high amounts of its mRNA have been detected in the heart, skeletal muscle, pancreas, liver and placenta (17) . The structural hallmark of WDR36 is the presence of multiple WD40 repeats which are conserved structural motifs of 40 amino acids that often terminate in a tryptophan-aspartic acid (WD) dipeptide. WD40 repeat proteins have been implicated in a wide variety of cellular functions, such as cell division, cell fate determination, gene transcription, transmembrane signaling, mRNA modification and vesicle fusion (36, 37) . The underlying common function of all WD repeat proteins is to coordinate multi-protein complex assemblies, where the repeating units serve as a rigid scaffold for protein interactions (36, 37) . According to a computed protein structure, WDR36 contains 14 WD40 repeats which fold into two connected seven-bladed b-propellers (38). The primary structure of WDR36 shows similarity to that of Utp21 (38) , an essential nucleolar ribonucleoprotein in the yeast Saccharomyces cerevisiae. Utp21 is part of the small subunit (SSU) processome (39) , a large ribonucleoprotein complex containing .40 proteins, which is required for the maturation of the 18S rRNA of the SSU of the ribosome (40) . Data reported in a recent study (41) suggest a similar function for Wdr36 in zebrafish, as Wdr36 is ubiquitously expressed in zebrafish, localizes to the nucleolus and loss-of-function phenotypes result in reduced levels of 18S rRNA.
To clarify the functional role of WDR36 in the mammalian organism, we generated mutant mice with a targeted deletion of Wdr36. In the present study, we report that the loss of WDR36 in mice leads to preimplantation embryonic lethality. Essentially, similar effects are observed when WDR36 mRNA is depleted in mouse embryos by RNA interference, while depletion of WDR36 mRNA in human cells in vitro causes apoptotic cell death. In parallel pulse-chase-labeling experiments, we show that knockdown of WDR36 expression results in a delay of 18S rRNA processing and provides evidence that WDR36 is involved in the formation of SSU rRNA in mammalian cells.
RESULTS

Targeted removal of Wdr36 leads to early embryonic death
For gene deletion, we replaced the first 16 exons of Wdr36 with a lacZ-floxed pgk-neomycin cassette as described in Materials and Methods (Fig. 1A) . Following germ-line transmission, genotyping of newborn pups was performed by Southern blot hybridization or PCR. Only heterozygous Wdr36 +/2 mice or wild-type littermates were detected, strongly indicating that a complete deletion of Wdr36 is lethal during prenatal development (Fig. 1B) . Next, heterozygous Wdr36-deficient mice were crossed with each other to obtain preimplantation embryos for genotyping. By using a nested PCR approach, we were now able to detect Wdr36 2/2 embryos, in addition to embryos with Wdr36
and wild-type genotype (Fig. 1C) . Subsequently, we took A 585 bp PCR fragment is specific for the mutant locus which replaces the wild-type locus normally detected as 896 bp fragment. (C) Nested PCR using as template DNA from embryos following mating of heterozygous Wdr36-deficient animals. A 319 bp fragment is specific for the mutant locus which replaces the wild-type locus normally detected as a 577 bp fragment.
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zygotes into culture and observed their development to blastocyst stage. Out of 66 zygotes that were cultured, 15 did not reach blastocyst stage, but instead ceased to develop and degenerated 3.5 days post coitum (dpc). In degenerating embryos, the inner cavity or blastocoel of blastocysts did not form and the embryonic cells became detached from their zona pellucida to clump together to a cluster. PCR analysis confirmed that all of those 15 embryos were homozygous Wdr36 deficient (Fig. 2) . Among the 51 embryos that reached blastocyst stage, 17 blastocysts were found to be of wild-type genotype, while 34 were heterozygous Wdr36 deficient (Fig. 2) . Overall, the analysis of cultured embryos confirmed that the loss of Wdr36 is lethal during preimplantation stages of embryonic development, and pointed towards a Mendelian inheritance of the mutant Wdr36 locus.
Deficiency in WDR36 leads to apoptotic cell death
Since Wdr36-deficient embryos degenerate during preimplantation stages, we hypothesized that the lack of WDR36 causes apoptotic death of blastomeres. To test this hypothesis, we wanted to investigate the effects of WDR36 deficiency in a cell culture model by using RNA interference. We first analyzed by real-time RT -PCR several primary and immortalized human cell lines with regard to their endogenous WDR36 expression, and observed a relative high expression in both primary human trabecular meshwork (HTM) cells and in cells of an immortalized cell line (HTM-N) derived from HTM (Fig. 3) . In contrast, the expression of WDR36 was considerably weaker in primary human optic nerve astrocytes, primary human retinal pigmented epithelial cells, primary human retinal microvascular endothelial cells and in HeLa cells (Fig. 3) . Next, we generated two independent siRNA (siRNA 1 and siRNA 2) species to knockdown the expression of WDR36 mRNA in HTM-N cells. After repeated transfection of specific siRNA for three consecutive times, we were able to significantly (P , 0.05) decrease the amounts of WDR36 mRNA in HTM-N cells to 23.5 + 0.6% (siRNA 1) or 45.5 + 9.9% (siRNA 2) when compared with control (lipofectamine treated) cells, an effect that was not seen when nontarget siRNA was transfected (Fig. 4A) . The siRNA-induced Figure 2 . Phenotype of Wdr36-deficient embryos. Zygotes were obtained following mating of heterozygous Wdr36-deficient animals and kept in KSOM medium at 378C in humidified air containing 5% CO 2 . The same embryos were photographed at 1.5, 2.5, 3.5 and 4.5 dpc. Wild-type and heterozygous Wdr36-deficient embryos developed normally and reached blastocyst stage at 4.5 dpc. In contrast, homozygous Wdr36-deficient embryos did not reach blastocyst stage and degenerated at 4.5 dpc. Black arrows indicate the zona pellucida which is in contact with embryonic cells surrounding the blastocoel or inner cavity (asterisks) of blastocysts in wild-type and heterozygous Wdr36-deficient embryos. In the homozygous Wdr36-deficient embryo, the cells have become detached from the zona pellucida and clump together in a cluster (white arrow).
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Human Molecular Genetics, 2011, Vol. 20, No. 3 knockdown of WDR36 mRNA resulted in a significantly (P , 0.05) smaller number of HTM-N cells in treated culture dishes, while the number of cells in dishes treated with nontarget siRNA was not different from that of control dishes (Fig. 4B ).
To analyze whether the reduction in cell number was due to an increase in apoptotic cell death, we next determined the relative amounts of cytoplasmic histone-associated DNA fragments (mono-and oligonucleosomes) by ELISA. Significantly (P , 0.05 for siRNA 1 and P , 0.01 for siRNA 2) higher amounts of cytoplasmic nucleosomes were observed in WDR36-depleted cells following treatment with both species of WDR36 siRNA when compared with controls, while no difference was observed when control cultures were compared with those treated with non-target siRNA (Fig. 4C) . Subsequently, we investigated the relative mRNA amounts of genes that are typically upregulated during apoptotic cell death. By real-time RT -PCR, we observed a highly significant (P , 0.01) upregulation of BAX (BCL2-associated X protein), an apoptotic activator and member of the BCL2 protein family, in cells treated with WDR36 siRNA when compared with control cells (Fig. 4D) . In contrast, the amounts of BAX mRNA in cells treated with non-target siRNA were not significantly different from that of controls. Since the expression of BAX is regulated by the tumor suppressor TP53 (tumor protein 53, p53) and has been shown to be involved in TP53-mediated apoptosis, we next analyzed the expression of TP53 mRNA, which was also found to be significantly higher expressed in cells treated with WDR36 siRNA (P , 0.05, Fig. 4E ). In contrast, treatment with nontarget siRNA decreased the expression of TP53 when compared with controls. TP53 is known to upregulate the expression of CDKN1A (cyclin-dependent kinase inhibitor 1A, p21, Cip1), a molecule that is involved in caspasemediated apoptosis. By real-time RT -PCR, we observed significantly higher amounts of mRNA for CDKN1A in cell cultures transfected with siRNA 1 than in controls or in cells treated with non-target siRNA (P , 0.01, Fig. 4F ).
To analyze the possibility that an arrest in cell cycle contributed to the reduced number of cells, which was observed in HTM-N cells following WDR36 knockdown, we performed flow cytometry analyses for DNA content. No obvious differences regarding the number of cells in G1 or G2 stages were observed when comparing cells from cultures treated with siRNA specific for WDR36, non-target siRNA or lipofectamine-treated controls (Fig. 5 ).
Since our in vitro data strongly indicated that the knockdown of WDR36 mRNA causes apoptotic cell death, we finally investigated whether a similar knockdown would have comparable effects in situ. To this end, we generated siRNA specific against mouse WDR36 mRNA and injected it into the cytoplasm or into pronuclei of 0.5 dpc mouse zygotes. Most of the WDR36 siRNA-or non-target siRNA-injected zygotes developed a compacted morula (Fig. 6 , Table 1 ). Still, in the WDR36 siRNA group, only a minor percentage (4 out of 36 following cytoplasmic injection and 2 out of 16 following pronucleus injection) developed further to blastocyst stage, while the rest degenerated (Fig. 6 , Table 1 ). In degenerating embryos, the blastocoel did not form and embryonic cells detached from their zona pellucida to clump together to a cluster. In contrast, in the non-target siRNA group, only a minor percentage (3 out of 34 following cytoplasmic injection and 2 out of 18 following pronucleus injection) was found to be degenerated at 4.5 dpc, while the rest had developed to blastocyst stage ( Fig. 6 , Table 1 ).
In summary, the knockdown of WDR36 mRNA by RNA interference induced cell death both in cultured cells and in embryos, and the time course of embryonic degeneration following knockdown was similar to that observed in homozygous WDR36-deficient embryos.
WDR36 is localized in the nucleolus of mammalian cells
In a recent study, Skarie et al. (41) reported on sequence homologies between WDR36 and Utp21, a nucleolar protein in yeast. They also showed that epitope-tagged recombinant Wdr36 localizes to nucleolus and cytoplasm of zebrafish embryos. To shed light on the subcellular localization of WDR36 in mammalian cells, we performed double-labeling immunocytochemistry with antibodies against WDR36 and B23 (nucleophosmin, a nucleolar phosphoprotein involved in ribosome assembly and transport). In HTM-N cells, staining for both WDR36 and B23 overlapped and was specifically seen in nucleoli (Fig. 7A) . In parallel experiments, doublelabeling was investigated for WDR36 and PWP2 (periodic tryptophan protein homolog), another nucleolar protein involved in ribosome biogenesis and part of the SSU processome. Confocal microscopy showed that immunoreactivity for both proteins was clearly confined to nucleoli and overlapped in the same nucleolar compartment (Fig. 7B ). In addition, immunoreactivity for WDR36 was in the immediate vicinity of the nucleus. In an independent approach, we overexpressed recombinant and epitope-tagged WDR36 in HTM-N cells. Immunocytochemistry with antibodies against the myc-tag predominantly visualized strong immunoreactivity in nucleoli of cells (Fig. 7C) . In contrast to the findings for wild-type WDR36, some faint immunoreactivity against the myc-tag of recombinant WDR36 was also seen dispersed throughout the cytoplasm of HTM-N cells. Overall, our immunocytochemical data strongly indicated that WDR36 is a nucleolar protein in mammalian cells. 
WDR36 functions in ribosome biogenesis
Utp21, the putative homolog of WDR36 in yeast, is a component of the SSU processome, a large ribonucleoprotein complex required for the biogenesis of 18S rRNA. The SSU processome participates in a series of events in which primary 47S/45S pre-rRNA is cleaved to yield 18S rRNA, a process that involves two alternative pathways and various intermediate pre-rRNAs in human cells (Fig. 8) . 47S/45S pre-rRNA contains, in addition to 18S rRNA, 5.8S rRNA and 28S rRNA, internal transcribed spacers (ITS-1 and ITS-2) and is flanked by external transcribed spacers (ETS). Since ITS1 is removed during the last cleavage steps from 18S precursor rRNA, we hypothesized that by using a probe against ITS-1 we should be able to examine the pre-rRNA maturation process and to visualize if the knockdown of As expected, the ITS-1 probe hybridized with 47S/45S, 41S, 30S and 21S pre-RNAs which all contain ITS-1, but not with mature 18S rRNA (Fig. 9 ). In addition, the ITS-1 probe hybridized with a band which migrated very close to that of large subunit 28S rRNA, an observation which we attributed to sequence homologies between ITS-1 and sequences within 28S rRNA, and the extreme high copy number of 28S rRNA. An alternative explanation is the detection of an additional 26S pre-rRNA band resulting from processing of 30S pre-rRNA in the 5 ′ -ETS region as described previously (42) . Most noteworthy, a substantial decrease in the amounts of 21S pre-rRNA, the direct precursor of 18S rRNA, was observed following knockdown of WDR36 mRNA when compared with controls (lipofectamine-treated cells) or cells transfected with non-target siRNA (Fig. 9) . We next examined pre-rRNA processing in HTM-N cells depleted of WDR36 by pulse-chase labeling with L-[methyl-3 H]methionine, which served as a methyl group donor for methylation of prerRNAs. Cells were labeled for 30 min, and chase with cold methionine was performed for up to 60 min. HTM-N cells treated with WDR36 siRNA 1 and 2 displayed a different processing pattern when compared with control cells as the formation of 18S rRNA was substantially delayed after a 30 min chase (Fig. 10) . In parallel, there was a build-up of the amounts of 47S/45S pre-rRNA and an increase in the ratio of newly produced 28S rRNA versus 18S rRNA following a 60 min chase (Fig. 10) . In both northern blot (Fig. 9 ) and pulse-chase experiments (Fig. 10) , small differences regarding the amounts of pre-rRNA were observed between the two controls, e.g. lipofectamine-treated cells or cells transfected with non-target siRNA. Such differences were regarded as not relevant and due to minor differences in loading.
In summary, both northern blot and pulse-chase-labeling experiments provided evidence for a delay in the maturation of 18S rRNA following WDR36 depletion, and for a role of WDR36 in the formation of SSU rRNA in mammalian cells.
DISCUSSION
We conclude that WDR36 is an essential nucleolar protein in mammalian cells which is involved in the processing of SSU 18S rRNA. This conclusion rests upon (i) the observation that homozygous Figure 6 . Phenotype of embryos treated with siRNA. siRNA was injected into the cytoplasm or one of the pronuclei, and zygotes were kept in KSOM medium at 378C in humidified air containing 5% CO 2 . The same cultures were photographed at 1.5, 2.5, 3.5 and 4.5 dpc. Non-injected or embryos injected with non-target siRNA develop to blastocysts with a typical inner cavity or blastcoel (asterisks). Some of the embryos are already seen to hatch from their zona pellucida (white arrow). In contrast, embryos injected with WDR36 siRNA do not reach blastocyst stage and degenerate at 4.5 dpc. The black arrow indicates the zona pellucida from which the cells have become detached to clump together in a cluster (white arrow). WDR36-deficient embryos degenerate before reaching blastocyst stage, (ii) the findings that depletion of WDR36 mRNA by RNA interference results in both apoptosis of HTM cells and degeneration of preimplantation mouse embryos, (iii) the nucleolar localization of both wild-type and epitope-tagged recombinant WDR36 and finally (iv) the observation that the depletion of WDR36 mRNA results in the delay of 18S rRNA maturation.
Wdr36 is an essential nucleolar protein
During mammalian development, maternally derived mRNAs direct only the first few cleavage divisions. In a process termed maternal-to-zygotic transition (MZT), maternal RNAs and proteins are eliminated, and zygotic transcription is initiated (43, 44) . In the mouse embryos, zygotic transcription is activated at the two-cell stage and a large fraction of maternally supplied mRNAs, rRNAs and ribosomes is degraded during this stage (45 -48) . Comparable changes are observed regarding the nucleolus, the site of ribosome-subunit biogenesis in eukaryotic cells (49) . The maternally derived nucleoli of the two pronuclei disassemble after pronuclear fusion (50), while zygotic transcription of ribosomal RNA initiates at the Figure 8 . Schematic of pre-rRNA processing in human cells [adapted from (82) and (42)]. It is not surprising though that mouse embryos with a targeted null mutation in genes that encode for proteins critically involved in ribosomal RNA synthesis or processing in the nucleolus such as RBM19 (58), pescadillo-1 (59), fibrillarin (60), RPO1 -2 (61), RPS19 (62) or SURF6 (63) typically fail to develop beyond the morula stage. The nucleolar localization of WDR36 along with the observation that homozygous Wdr36-deficient embryos degenerate before reaching blastocyst stage strongly indicates an important role for WDR36 in the processing of ribosomal RNA in the nucleolus. Similar to the results of Skarie and Link (41) in zebrafish embryos, we observed that an epitope-tagged recombinant WDR36 localizes to the nucleolus of HTM-N cells, but does also show a cytoplasmic localization. We regard the cytoplasmic localization of recombinant WDR36 as an unspecific consequence of overexpression, since we observed a more specific nucleolar labeling of wild-type WDR36 by immunocytochemistry of HTM-N cells, along with co-staining of typical nucleolar proteins such as B23/nucleophosmin or PWP2. Findings reported following mass spectrometry analysis of nucleoli isolated from human cells support our findings, as WDR36 was found to be a component (http://www.lam ondlab.com/NOPdb/) (64) .
A characteristic finding which was reported for mouse embryos that are deficient in nucleolar proteins is an increase in apoptosis (58, 60, 61) , a scenario that we also observed when WDR36 was depleted in HTM-N cells and which may well account for degeneration of WDR36-deficient embryos. Apoptosis following depletion of Wdr36 mRNA in zebrafish by viral insertion in the wdr36 gene or by morpholino anti-sense probes was also reported by Skarie and Link (41) . Noteworthy, the depletion of Wdr36 in zebrafish embryos did not cause degeneration of embryos during early developmental stages as observed here in the mouse. In contrast, zebrafish embryos developed well past the onset of organogenesis, although substantial developmental defects were observed in the head, gut and eye formation. Comparable differences regarding the phenotype of mouse and zebrafish embryos that are deficient in the respective homologous protein were also reported for other nucleolar proteins such as RBM19 (65), pescadillo-1 (66) and Rps19 (67, 68) . A likely explanation for these differences is the fact that, in zebrafish, MZT and zygotic gene activation occur considerably later than during mammalian development, while maternal factors continue to perform essential functions well after MZT (69) . Alternatively, viral insertion or treatment with morpholino anti-sense probes very likely does not lead to a complete depletion of Wdr36 mRNA and some residual protein may still be translated, a scenario quite unlike to the situation in a mouse embryo after a targeted disruption of Wdr36.
WDR36 and the SSU processome
Maturation of 18S rRNA requires the removal of externally and internally transcribed spacers, a process that is mediated by the SSU processome, which is a large ribonucleoprotein complex containing .40 proteins (70). The SSU processome was discovered in yeast and most of our information concerning it has been obtained from studies in this organism, although some data are available on its role in human cells (71, 72) . In yeast, the SSU processome consists of several subcomplexes such as the bUTP complex which contains Utp21, the yeast homolog of WDR36. Our data show that the depletion of WDR36 delays the maturation of 18S rRNA, indicating that the functions of WDR36 and Utp21 are similar and conserved from yeast to mammals. The observation that the maturation of 18S rRNA was retarded, but not disrupted, appears to indicate that the depletion of WDR36 was not complete following the knockdown of its mRNA by RNA interference. The reduced amounts of WDR36 very likely slowed down the activity of the SSU processome, but did not completely block it.
WDR36 and its role in diseases
In recent years, a growing number of rare, inherited diseases have been identified, which are caused by mutations in genes that are involved in the biogenesis of the SSU processome or that of small nucleolar ribonucleoproteins or ribosomal proteins (73) . For almost all of the encoded proteins, the homolog in yeast is essential. In addition, several of the proteins have been shown to be essential for the mammalian organism. Nearly all of the diseases that are caused by genetic failures in ribosomal processing or synthesis result from haploinsufficiency which leads to the activation of apoptosis via the p53 pathway in distinct, yet different, types of tissues. It appears, therefore, reasonable to assume that haploinsufficiency is the mechanism which accounts for the onset of POAG in patients with mutations in WDR36. Apoptotic death of RGC is the cause of vision loss in POAG (74, 75) and mutations in WDR36 might confer a higher vulnerability to stimuli driving RGC towards apoptosis such as an increase in IOP. On the other hand, dominant negative effects may be involved in the role of WDR36 in POAG, as transgenic mice that overexpress mutant forms of WDR36 under control of a constitutive ubiquitous promoter develop retinal degenerations and show abnormalities in axonal outgrowth (76) . Clearly, heterozygous Wdr36-deficient mice are an attractive tool to study the effects of haploinsufficiency on RGC in the mouse eye, and such studies are already underway in our laboratory.
MATERIALS AND METHODS
Targeting construct and generation of Wdr36-deficient mice
The genomic sequence of the Wdr36 locus of 129/Ola mice was obtained by PCR. A 2.0 kb fragment immediately upstream of the translation start was obtained by PCR and used as 5 ′ -homology region (Supplementary Material, Table S1 ). The start codon of lacZ was placed exactly over the start codon. Table S1 ). The plasmid pTVflox -Wdr36 -KO
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Human Fig. S1 ) was linearized at a unique NotI site and electroporated into R1 embryonic stem (ES) cells (129 X1 × 129 S1), which were then selected with G418 (200 mg/ml) and ganciclovir (2 mM). Homologous recombination resulted in the deletion of the start ATG and the first 16 exons. The deleted genomic region was replaced with a lacZ-floxed pgk-neomycin cassette. For negative selection, an hsv-tk cassette was placed outside the 5 ′ -homology region. Genotyping was performed by Southern hybridization of ES cell DNA using nonradioactive-labeled DIG probes according to the manufacturer's instructions (DIG Application Manual for Filter Hybridization, Roche Applied Science, Mannheim, Germany). ES cell clones were screened by Southern blotting with a 704 bp 5' probe which recognized a 9042 bp fragment of the wild-type allele and a 4890 bp fragment of the targeted allele in genomic DNA digested with EcoRV. An appropriate integration of the 3 ′ end of the targeting construct was verified by using a 493 bp 3
′ probe on ES cell DNA double-digested with NcoI and XhoI. The probe hybridized to a 5280 bp fragment in the targeted allele, as opposed to a 6142 bp fragment in the wild-type allele. The targeted ES cells were injected into C57BL/6J blastocysts to generate chimeras. Chimeric males transmitted the targeted allele to their offspring. Genotyping was routinely performed by PCR analysis, using a common upper primer located in the 5 ′ flank upstream of the start codon (5 ′ -GACCTCCCTGAA AATGAGTCAC-3 ′ ) and two lower primers located in intron 1 of Wdr36 (5 ′ -GGATAGCGAGCAAATATGAAGG-3 ′ ) and lacZ (5 ′ -AATGGGATAGGTTACGTTGGTG-3 ′ ) resulting in a 896 bp PCR fragment for the wild-type allele and a 585 bp fragment for the targeted allele. DNA was obtained from tail tips, or in the case of embryos, from yolk sacs (Reichert's membrane). PCR was performed in 25 ml reaction mixtures containing standard buffer, 0.1 mM of each primer, 1 mM dNTPs, 2.5 mM MgCl 2 , 12% glycerol, 0.2 mM cresol red sodium salt (Sigma, Taufkirchen, Germany) and 0.25 U TaqPolymerase (New England Biolabs, Frankfurt am Main, Germany). The cycling conditions consisted of an initial 2 min denaturing step at 948C, followed by 35 cycles for 20 s at 948C, for 20 s at 588C, for 45 s at 728C. Mice were housed at a 12 h light/dark cycle under standardized conditions of 62% air humidity and 218C room temperature (RT).
Preimplantation stage embryos
For timed pregnancies, Wdr36 +/2 females received an i.p. injection of serum gonadotropin from a pregnant mare (5 IU/ animal; Sigma), followed 48 h later by human chorionic gonadotropin (5 IU/animal; Sigma). Mice were then allowed to mate with Wdr36 +/2 males. The males were removed the next morning and the females were examined for the presence of a vaginal plug. Preimplantation stage embryos (zygotes at 0.5 dpc, and blastocysts at 3.5 dpc) were collected by flushing the uterus of plugged females with M2 medium (Sigma). Flushed embryos were cultured individually in KSOM (Millipore, Billerica, USA) microdrop cultures at 378C in humidified air containing 5% CO 2 over several days. The growth patterns of embryos were microscopically examined and photographed. DNA was prepared by incubation of individual embryos with 20 ml of lysis buffer [50 mM Tris -HCl, 0.5% Triton X-100, proteinase K (500 mg/ml), pH 8.0] for 4 h at 558C, followed by incubation at 908C for 10 min. Two microliters of embryonic DNA were used in the first round of a nested PCR strategy. First-round primers were identical to that used for genotyping of litters. For the second round of amplification, 1 ml of the first-round reaction mixture was added to two separate reaction mixtures, each containing the internal forward wild-type primer (5 ′ -CAACCAAGAGGA AACCAACC-3 ′ ) and an internal reverse wild-type primer (5 ′ -CTAAGTGCAAGGGCACAAGG-3 ′ ) or an internal reverse lacZ primer (5 ′ -GGCGATTAAGTTGGGTAACG-3 ′ ). PCR conditions were identical to that described above. Microinjection was performed under an inverted microscope (Olympus IX71) at 320-fold magnification with differential interference contrast (DIC) using electromechanical micromanipulators (Eppendorf TransferMan NK2). Twenty micromolars of siRNA were injected into the cytoplasm (10 -20 pl) or one of the pronuclei (2 -4 pl) of zygotes with fine-drawn glass capillaries of a 0.5-2 mm opening diameter under a constant pressure of 10 -50 hPa depending on the opening size. The pressure was produced and regulated by a FemtoJet compressor (Eppendorf). All injected embryos were allowed to develop to the blastocyst stage in culture. The growth patterns of embryos were microscopically examined and photographed.
Cell culture
Primary HTM cells, human optic nerve astrocytes, human retinal pigmented epithelium cells, human retinal microvascular cells and immortalized simian virus 40 (SV40) transformed HTM cells (HTM-N) were cultured as described previously (77) (78) (79) (80) (81) . To generate a cell line with stable overexpression of WDR36, the full-length cDNA of mouse WDR36 was cloned and ligated into plasmid pCDNA3.1A (Invitrogen, Karlsruhe, Germany) to allow expression of WDR36 with both a C-terminal c-myc epitope and a 6x His tag under control of the cytomegalovirus promoter. HTM-N cells transfected with plasmid mmWdr36 -pcDNA.3.1/myc -His were cultured in the presence of 1% G418 (PAA, Pasching, Austria). For transfection, lipofectamine 2000 was used according to manufacturer's instructions (Invitrogen). The number of cultured cells was assessed by automated counting (CASY Cell Counter and Analyser TT, Schärfer, Reutlingen, Germany). For analyzing cell-cycle profiles, cells were fixed with 70% ethanol overnight at 2208C, incubated with 100 mg/ml of RNase A for 60 min at 378C followed by 50 mg/ml of propidium iodide for 30 min. Data were acquired on a flow cytometer (Partec CA-III, Münster, Germany) and analyzed using WinMDI 2.8 software (J. Trotter, The Scripps Institute, Flow Cytometry Core Facility). Cell death detection ELISA (Roche) was performed according to the manufacturer's instructions.
Generation and transfection of siRNA
Target sequences for mouse and human WDR36 siRNA were designed according to the Ambion web-based criteria and generated with a Silencer siRNA construction kit (Ambion, Austin, TX, USA). Different WDR36 siRNAs were tested in initial transfection experiments and subsequent RT -PCR ′ (antisense) were used. To assess the effects of WDR36 siRNA on gene expression, cells were transfected three times at 24, 48 and 72 h after seeding and supplemented after 4 h with culture medium. After the last transfection, the cells were incubated for 48 h before harvesting. siSTABLE non-targeting siRNA 1 (Dharmacon, Chicago, USA), a chemically modified (for increased stability) control siRNA with at least four mismatches to any human, mouse, or rat gene, was used as a negative control. Primers used for generation of mouse-specific WDR36 siRNA as used in microinjection assays were 5 ′ -AAGCGCCGCTTCTACGTGACGCCTGTCTC-3 ′ (sense) and 5 ′ -AACGTCACGTAGAAGCGGCGCCCTGTCTC-3 ′ (antisense).
RNA isolation and analysis
Total RNA was extracted with TRIzol (Invitrogen) according to manufacturer's recommendations. Structural integrity of RNA samples was confirmed by electrophoresis using 1% (w/v) agarose gels. The RNA concentration was determined by absorbance at 260 nm. First-strand cDNA was prepared from total RNA, using the iScript cDNA Synthesis kit (BioRad, München, Germany) according to the manufacturer's instructions. Real-time RT -PCR was performed on a BioRad iQ5 Real-Time PCR Detection System (BioRad) with the temperature profile as follows: 40 cycles for 10 s melting at 958C, 40 s of annealing and extension at 608C. Primer pairs (Table 2) were purchased from Invitrogen and extended over exon-intron boundaries. RNA that was not reverse transcribed served as a negative control for realtime PCR. Guanine nucleotide binding protein 2 (GNB2L) served as a housekeeping gene. For northern blot analysis, RNA was size fractionated on a 1% agarose gel containing 3% formaldehyde and blotted onto a positively charged nylon membrane (Roche). After transfer, the blot was crosslinked using an UV Stratalinker 1800 (Stratagene, La Jolla, CA, USA) followed by methylene blue staining (0.03% methylene blue, 0.3 M sodium acetate, pH 5.2) to assess the amount and quality of the RNA. Prehybridization was performed for 45 min at 688C in a Hybridizer HB-1000 (UVP Laboratory Products, Upland, CA, USA) using the Dig EasyHyb-buffer (Roche). Antisense RNA probes were generated of genomic DNA using ITS-1 fwd (5 ′ -GAGAACTCG GGAGGGAGAC-3 ′ ) and ITS-1-T7 rev (5 ′ -TAATACGACT CACTATAGGGAGACGCCCTAGCGGGAAG-3 ′ ) primers and labeled using DIG RNA Labeling kit (Roche) according to the manufacturer's instructions. Hybridization was performed for 16-18 h at 688C. Membranes were washed two times for 5 min with 2× saline-sodium citrate (SSC) and 0.1% sodium dodecyl sulfate (SDS) at RT followed by two washes with 0.2% SSC and 0.1% SDS at 708C for 15 min. After an additional washing step with maleic acid wash buffer (0.1 M maleic acid, 0.15 M sodium chloride, 0.3% Tween 20, pH 7.5), the membrane was blocked for 30 min in 1× DIG-blocking reagent (Roche) at RT. Then the blot was incubated for 30 min with Anti-DIG-antibody (1:10 000 in 1× DIG-blocking reagent (Roche), washed with maleic acid wash buffer (2 × 15 min, RT) and equilibrated in detection buffer (100 mM Tris -HCl, 100 mM NaCl; pH 9.5) for 10 min. For detection, blots were incubated with chemiluminescence substrate CDP-STAR (Roche) and documented in a LAS 3000 Intelligent Dark box (Fujifilm, Düsseldorf, Germany).
Pulse chase
For pulse-chase experiments, a knockdown of WDR36 was performed in HTM-N cells as described above. Forty-eight hours after the last transfection, cells were washed two times with phosphate-buffered saline (PBS) followed by 30 min incubation with methionine-free medium. Twenty-five microcurie L-[methyl-3 H]-methionine was added to the medium, and the cells were incubated for 30 min at 378C, 7% CO 2 . The radioactive medium was replaced by normal growth medium and cells were harvested after 15, 30 and 60 min of chase time.
Immunocytochemistry HTM-N cells were grown on microscope slides as described above. After incubation, cells were fixed in 4% paraformaldehyde for 15 min, washed twice in 0.1 M PBS, pH 7.2, and subsequently incubated for 5 min in 0.1 M PBS containing 0.5% Triton X-100 followed by two washing steps with 0.1 M PBS. Cells were blocked for 45 min in 3% bovine serum albumin (BSA) and 0.1% Triton X-100 in 0.1 M PBS. Primary antibodies were added in appropriate dilutions [rabbit anti-WDR36 polyclonal (Abcam): 1:50, mouse anti-B23 polyclonal (Abcam): 1:500 and mouse anti-PWP2H polyclonal (Abcam): 1:75] in PBS/BSA (0.3%) and allowed to bind for 2 h at RT. After the cells were washed three times with PBS, secondary antibodies [highly cross adsorbed goat anti-rabbit conjugated to Alexa 488 (Invitrogen); highly cross adsorbed donkey anti-mouse conjugated to Cy3 (Jackson Immuno Research)] were added for 1 h at RT. 4
′ ,6-Diamidino-2-phenylindole (DAPI) was used to counterstain nuclear DNA. Slides were mounted in a medium containing DAPI (Vectashield; Vector Laboratories, Burlington, CA, USA), and analyzed under a fluorescence microscope (Zeiss Axio Imager; Carl Zeiss AG, Oberkochen, Germany). To control for non-specific binding of secondary antibodies, negative control experiments were performed, which were handled similarly, with the exception that the cells were incubated in PBS/BSA instead of primary antibody.
Statistics
All results are expressed as mean + SEM. Comparisons between the mean variables of the two groups were made by a two-tailed Student's t-test. P-values ,0.05 were considered to be statistically significant.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
